CSIMarket
 


Glucotrack Inc   (GCTK)
Other Ticker:  
 
 

GCTK's Net Cash Flow Growth by Quarter and Year

Glucotrack Inc 's Net Cash Flow results by quarter and year




GCTK Net Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -0.95 -0.97 -2.59
III Quarter September -1.89 -0.62 -0.89 12.00
II Quarter June 7.77 -0.94 -0.98 0.33
I Quarter March -1.32 -1.27 -0.93 0.00
FY   4.56 -3.78 -3.77 9.74



GCTK Net Cash Flow third quarter 2022 Y/Y Growth Comment
Glucotrack Inc in the third quarter 2022 recorded net cash outflow of $ -1.89 millions.

Looking into third quarter 2022 results within Medical Equipment & Supplies industry 13 other companies have achieved higher Net Cash Flow growth. While Glucotrack Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 509 in the third quarter 2022.




GCTK Net Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - 32366.67 %

Financial Statements
Glucotrack Inc 's third quarter 2022 Net Cash Flow $ -1.89 millions GCTK's Income Statement
Glucotrack Inc 's third quarter 2021 Net Cash Flow $ -0.62 millions Quarterly GCTK's Income Statement
New: More GCTK's historic Net Cash Flow Growth >>


GCTK Net Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - 3536.36 %
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - 32366.67 %




Net Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #14
Healthcare Sector #74
Overall #509

Net Cash Flow Y/Y Growth Statistics
High Average Low
3581.36 % 1164.99 % -62.1 %
(Mar 31 2020)   (Dec 31 2014)
Net Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #14
Healthcare Sector #74
Overall #509
Net Cash Flow Y/Y Growth Statistics
High Average Low
3581.36 % 1164.99 % -62.1 %
(Mar 31 2020)   (Dec 31 2014)

Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Glucotrack Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
3581.36 % 1164.99 % -62.1 %
(Mar 31 2020)  


GCTK's III. Quarter Q/Q Net Cash Flow Comment
Recent net cash outflow of -1.89 millions by Glucotrack Inc appear even less good compare to the net cash outflow 7.77 millions a quarter before.

Within Medical Equipment & Supplies industry 13 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Glucotrack Inc 's Net Cash Flow growth quarter on quarter, overall rank is 509.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #14
Healthcare Sector #74
Overall #509
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #14
Healthcare Sector #74
Overall #509
Net Cash Flow Q/Q Growth Statistics
High Average Low
3581.36 % 1164.99 % -62.1 %
(Mar 31 2020)  


GCTK's III. Quarter Q/Q Net Cash Flow Comment
III. Quarter 2022 results of -1.89 millions by Glucotrack Inc appear even more unfavourable considering the 7.77 millions in the previous quarter.

Within Medical Equipment & Supplies industry 13 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Glucotrack Inc 's Net Cash Flow growth quarter on quarter, overall rank is 509.


Glucotrack Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Cash Flow 12 Months Ending $ 3.62 $ 4.89 $ -3.83 $ -3.78 $ -3.80
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) -25.97 % - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 515 # 0 # 0 # 0 # 0




Cumulative Net Cash Flow growth Comment
In the Sep 30 2023 period, Glucotrack Inc had cumulative twelve months Net Cash Flow of $ 4 millions compare to net cash outflow of $ -4 millions a year ago.

Glucotrack Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-146.73 %
-162.98 %
-187.86 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 86
S&P 500 # 515
Cumulative Net Cash Flow growth Comment
In the Sep 30 2023 period, Glucotrack Inc had cumulative twelve months Net Cash Flow of $ 4 millions compare to net cash outflow of $ -4 millions a year ago.

Glucotrack Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
-146.73 %
-162.98 %
-187.86 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 86
S&P 500 # 515




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
GCTK's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for GCTK's Competitors
Net Cash Flow Growth for Glucotrack Inc 's Suppliers
Net Cash Flow Growth for GCTK's Customers

You may also want to know
GCTK's Annual Growth Rates GCTK's Profitability Ratios GCTK's Asset Turnover Ratio GCTK's Dividend Growth
GCTK's Roe GCTK's Valuation Ratios GCTK's Financial Strength Ratios GCTK's Dividend Payout Ratio
GCTK's Roa GCTK's Inventory Turnover Ratio GCTK's Growth Rates GCTK's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2023
Qrons Inc 343.36%$ 343.363 millions
Vericel Corporation327.94%$ 327.938 millions
Mirati Therapeutics Inc 287.63%$ 287.630 millions
Envista Holdings Corporation279.96%$ 279.956 millions
Repligen Corp271.45%$ 271.446 millions
Iovance Biotherapeutics Inc 266.44%$ 266.437 millions
Orasure Technologies Inc249.29%$ 249.293 millions
Teladoc Health Inc 228.82%$ 228.824 millions
Immunitybio inc 218.18%$ 218.182 millions
Axogen inc 205.37%$ 205.366 millions
Amarin Corp Plcuk202.58%$ 202.576 millions
Trevena inc 175.52%$ 175.523 millions
Ikena Oncology Inc 173.39%$ 173.390 millions
Neurocrine Biosciences Inc 173.01%$ 173.006 millions
Aquestive Therapeutics Inc 160.06%$ 160.063 millions
Actavia Life Sciences Inc 151.37%$ 151.374 millions
Cytokinetics Incorporated146.32%$ 146.316 millions
Avanos Medical Inc 140.95%$ 140.952 millions
Lantheus Holdings Inc 134.62%$ 134.620 millions
Skye Bioscience Inc 125.55%$ 125.554 millions
Viridian Therapeutics Inc 122.74%$ 122.742 millions
Durect Corp121.69%$ 121.694 millions
Regeneron Pharmaceuticals Inc 118.81%$ 118.815 millions
Ensign Group Inc105.70%$ 105.703 millions
Vertex Pharmaceuticals Inc103.68%$ 103.679 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com